The global qPCR reagents market was dominated by Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories Inc. (U.S.), and Qiagen N.V. (Netherlands). These top three market players jointly accounted for ~75.0% of the global qPCR reagents market, in 2014. Other key players present in global qPCR reagents market included F. Hoffmann-La Roche, Ltd. (Switzerland), Agilent Technologies Inc. (U.S.), Takara Bio (Japan), Affymetrix Inc. (U.S.), Promega Corporation (U.S.), Sigma-Aldrich Corporation (U.S.), and Quanta Biosciences Inc. (U.S.), among others.

Thermo Fisher Scientific Inc. (U.S.) held the leadership position in the global qPCR reagents market, with a share of ~40%, in 2014. The company has a broad product portfolio for qPCR reagents, including master mixes, enzymes, nucleotides, primers, reagents, as well as consumables, among others. The company has a strong geographic presence in more than 50 countries across the globe, with key markets being the U.S., China, Germany, and the U.K. The company focuses mainly on the development of technologically advanced qPCR instruments and supporting reagents that can be used for multiple applications. In line with this strategy, Thermo Fisher Scientific has launched several qPCR reagents in the last three years, including SYBR Green master mixes and Taqman qPCR kits, among others. These product launches helped the company to expand its existing product portfolio and enlarge its revenue base in the global qPCR reagents market.

Bio-Rad Laboratories, Inc. (U.S.) held the second position in the global qPCR reagents market, with a share of ~23% in 2014. The company owns a well-established market image in the life science and clinical diagnostics market, with a broad range of technologically advanced products (including qPCR reagents). To strengthen its current position and gain a larger market share, Bio-Rad Laboratories is aggressively focused on developing innovative qPCR reagents.

In the global qPCR reagents market, leading players adopted various growth strategies such as new product launches and product development; agreements, collaborations, and partnerships; mergers, demergers, and strategic acquisitions; geographic expansions; awareness campaigns; and research funding and grants. Market players adopted these strategies to develop novel qPCR reagents, expand their product portfolios, enter emerging markets, and increase their market shares. In addition to the top three market players, companies such as F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., Takara Bio, and Quanta Biosciences Inc. adopted new product launches as their key growth strategy to widen their product offerings & to strengthen their pipeline development capabilities in the fast-growing qPCR reagents market.